Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype
Pallavi Galera(National Institutes of Health Clinical Center), Wenbin Xiao(Memorial Sloan Kettering Cancer Center), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Mark B. Geyer(Memorial Sloan Kettering Cancer Center), Jacob L. Glass(Memorial Sloan Kettering Cancer Center), Yanming Zhang(Memorial Sloan Kettering Cancer Center), Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Deepika Dilip(Memorial Sloan Kettering Cancer Center), Eytan M. Stein(Memorial Sloan Kettering Cancer Center), Tanmay Mishra(Vellore Institute of Technology University), Alexander Chan(Memorial Sloan Kettering Cancer Center), Christopher Famulare(Memorial Sloan Kettering Cancer Center), Mikhail Roshal(Memorial Sloan Kettering Cancer Center), Andriy Derkach(Memorial Sloan Kettering Cancer Center), Ying Liu, Qi Gao, K KRAMER(Memorial Sloan Kettering Cancer Center), Sonali Persaud(Memorial Sloan Kettering Cancer Center), Mahak Kathpalia(Memorial Sloan Kettering Cancer Center), Douglas A. Mata(Foundation Medicine (United States))
Cited by 9
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
|Leukemia|2022|3.6k